Amprius Technologies (NYSE:AMPX) Stock Price Down 5% - Here's What Happened

Key Points

• Amprius shares fell about 5% to roughly $18.15 on Friday on ~9.4M shares traded (up ~3% vs. average), despite a consensus "Moderate Buy" rating from analysts and a $19.75 average target price.
• The company beat quarterly expectations (EPS -$0.01 vs. -$0.04; revenue $25.23M vs. $22.91M) but remains unprofitable with a ~60% negative net margin and issued FY2026 EPS guidance of about -$0.06 while sell-side forecasts call for roughly -$0.45 for the current year.
• There has been notable insider selling: insiders disposed of ~2.93M shares (~$37.8M) over the past 90 days (including a 155,565-share sale by director Steven Chu), though insiders still own about 12.9% of shares.

Amprius Technologies, Inc. (NYSE:AMPX - Get Free Report) dropped 5% during trading on Friday . The company traded as low as $17.74 and last traded at $18.1520. Approximately 9,395,300 shares were traded during trading, an increase of 3% from the average daily volume of 9,100,949 shares. The stock had previously closed at $19.11.

Wall Street Analysts Forecast Growth

A number of research firms recently issued reports on AMPX. William Blair reaffirmed an "outperform" rating on shares of Amprius Technologies in a research note on Friday, March 6th. Oppenheimer restated an "outperform" rating and issued a $17.00 target price on shares of Amprius Technologies in a report on Tuesday, December 23rd. Weiss Ratings reaffirmed a "sell (e+)" rating on shares of Amprius Technologies in a report on Wednesday, January 21st. B. Riley Financial lifted their price target on Amprius Technologies from $16.00 to $22.00 and gave the stock a "buy" rating in a research report on Monday, March 9th. Finally, Craig Hallum upped their price objective on Amprius Technologies from $17.00 to $21.00 and gave the company a "buy" rating in a research report on Friday, March 6th. Eight analysts have rated the stock with a Buy rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $19.75.

Amprius Technologies Price Performance

The firm has a market capitalization of $2.49 billion, a P/E ratio of -53.39 and a beta of 3.04. The firm has a 50-day moving average price of $12.67 and a two-hundred day moving average price of $11.40.

Amprius Technologies (NYSE:AMPX - Get Free Report) last posted its quarterly earnings results on Wednesday, March 4th. The company reported ($0.01) EPS for the quarter, topping analysts' consensus estimates of ($0.04) by $0.03. Amprius Technologies had a negative net margin of 60.30% and a negative return on equity of 24.29%. The firm had revenue of $25.23 million for the quarter, compared to analysts' expectations of $22.91 million. Amprius Technologies has set its FY 2026 guidance at --0.060 EPS. Sell-side analysts predict that Amprius Technologies, Inc. will post -0.45 earnings per share for the current fiscal year.

Insider Activity at Amprius Technologies

In other Amprius Technologies news, Director Steven Chu sold 155,565 shares of Amprius Technologies stock in a transaction on Thursday, March 12th. The stock was sold at an average price of $18.50, for a total transaction of $2,877,952.50. Following the completion of the sale, the director directly owned 127,339 shares of the company's stock, valued at $2,355,771.50. The trade was a 54.99% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CTO Constantin Ionel Stefan sold 25,366 shares of the company's stock in a transaction on Monday, February 23rd. The stock was sold at an average price of $10.16, for a total value of $257,718.56. Following the completion of the sale, the chief technology officer owned 723,330 shares of the company's stock, valued at $7,349,032.80. This represents a 3.39% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last ninety days, insiders sold 2,929,357 shares of company stock worth $37,783,110. Insiders own 12.90% of the company's stock.

Institutional Inflows and Outflows

Institutional investors have recently added to or reduced their stakes in the business. EWA LLC lifted its position in shares of Amprius Technologies by 3.8% in the 4th quarter. EWA LLC now owns 19,958 shares of the company's stock worth $157,000 after purchasing an additional 723 shares during the period. Victory Capital Management Inc. increased its holdings in Amprius Technologies by 14.7% during the third quarter. Victory Capital Management Inc. now owns 11,817 shares of the company's stock valued at $124,000 after buying an additional 1,516 shares during the period. Graham Capital Management L.P. raised its stake in Amprius Technologies by 3.2% in the fourth quarter. Graham Capital Management L.P. now owns 49,596 shares of the company's stock worth $391,000 after buying an additional 1,551 shares in the last quarter. The Manufacturers Life Insurance Company lifted its holdings in Amprius Technologies by 5.1% during the fourth quarter. The Manufacturers Life Insurance Company now owns 33,280 shares of the company's stock worth $263,000 after buying an additional 1,621 shares during the period. Finally, First Trust Advisors LP lifted its holdings in Amprius Technologies by 6.7% during the fourth quarter. First Trust Advisors LP now owns 32,744 shares of the company's stock worth $258,000 after buying an additional 2,066 shares during the period. Hedge funds and other institutional investors own 5.04% of the company's stock.

About Amprius Technologies

Amprius Technologies, Inc NYSE: AMPX is a U.S.-based developer of high-energy-density lithium-ion batteries that leverage silicon anode technology to deliver performance levels beyond conventional graphite-based cells. The company's batteries are designed to offer industry-leading gravimetric energy density, enabling longer run times and reduced weight for portable power applications. Amprius blends advanced materials science and scalable manufacturing processes to commercialize next-generation battery solutions.

At the core of Amprius' product portfolio are cylindrical and prismatic cells that employ a proprietary silicon nanowire anode, which supports high charge/discharge rates while maintaining cycle life.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.